Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study aims to evaluate the safety, efficacy, and pharmacokinetics of Ronkyla Plus, a combinational drug that forms a hydrogel at the injection site, promising a better experience of lipolysis injection for the treatment of superficial lipoma. The study consists of a Part I dose-escalation study to investigate the drug\'s maximum tolerated dose (MTD) for this indication and a Part II study for evaluating its relative bioavailability in comparison to an FDA-approved lipolysis injection, Kybella.
Epistemonikos ID: 71fb73bf193f6498c10a5d141e3a684d8e14332b
First added on: Nov 20, 2025